Bangladeshi medical tourism to Thailand is running at a scale the Thai embassy in Dhaka can now put numbers to, The Business Standard reported. Thitiporn Chirasawadi, Thailand’s ambassador to Bangladesh, set out the figures at an 11 April press conference in Dhaka hosted by Bangkok-based MedPark Hospital, and the picture is of a steady outbound corridor rather than a passing spike. The embassy, she said, is processing the demand rather than selling it, coordinating access for patients rather than intervening commercially.
Visa data behind the Bangladesh to Thailand corridor
The embassy processes roughly 9,000 visa applications a month, and “around 60% are for medical purposes,” Chirasawadi said, The Business Standard reported. On that basis nearly 65,000 Bangladeshis travel to Thailand each year for treatment, a volume that makes medical tourism the dominant reason Bangladeshi patients apply at all. Overall application numbers have climbed with it, the ambassador said, with daily processing reaching between 800 and 1,000 during peak seasons. The medical share is what gives the corridor its shape, and it is the medical share the embassy has built its logistics around.
That logistics question is not trivial for a country selling itself as a healthcare destination. Thailand moved from a manual visa system to an e-visa platform in early 2025, The Business Standard reported, and the switch brought early delays as the system absorbed the volume before settling into something faster. Standard processing for a medical visa now runs up to two weeks, which Chirasawadi called reasonable given demand, and the embassy advises patients to file at least two weeks before departure. Urgent cases are moved to the front, with the embassy keeping close coordination with hospitals across Thailand so patients who need immediate treatment are expedited past the standard timeline.
MedPark Hospital and the Bangladeshi patient segment
The host of the Dhaka briefing was also its clearest case study. MedPark Hospital, a 550-bed multidisciplinary facility in Bangkok, has been named to Newsweek’s World’s Best Hospitals list and is internationally accredited to the safety and quality standards international patients tend to check first. Kazi Sharhan Saif, MedPark’s manager of international marketing for Bangladesh and South Asia, said the hospital alone now treats thousands of Bangladeshi patients a year, a figure he put at nearly 300 per cent year-on-year growth in that segment, The Business Standard reported.
Growth of that order is a commercial signal as much as a clinical one. MedPark is building around the Bangladeshi patient rather than waiting for it, and the hospital is currently offering a 25 per cent discount on health check-ups for Bangladeshi patients, a promotional lever aimed at the diagnostics end of the funnel where first-time medical travellers usually enter. Tailored packages of this kind are how a hospital converts a general reputation into a named referral, and the discount tells you which segment MedPark has decided is worth buying.
Specialist care and the Bangladeshi referral network
The Dhaka event put clinical range on display alongside the numbers. MedPark fielded Dr Virat Pinyopornpanit, an internal medicine specialist, Dr Yongyut Kongthanarat, a radiation oncologist, and Dr Waiwit Sanguanwongwan, an orthopaedic surgeon, The Business Standard reported, a spread that maps onto the oncology and orthopaedic caseloads that drive most serious outbound medical tourism from South Asia.
The support around those specialists is where the corridor is actually held together. MedPark runs a dedicated help desk for Bangladeshi patients staffed by more than ten Bangla-speaking coordinators, and it maintains referral offices in Dhaka and Chattogram, The Business Standard reported. Referral offices inside the source market are the unglamorous part of medical tourism, and they are also the part that converts. They handle the coordination, the travel arrangements and the continuity of care that decide whether a patient who flew once flies again.
What the Thailand numbers actually show
Read against the five reasons patients cross borders for care, that treatment abroad is better, is the best available, is cheaper, is faster, or is simply unavailable at home, the Bangladesh to Thailand corridor runs mostly on the first two, capacity and confidence. Nearly 65,000 medical journeys a year is not a story about price alone, and it is not really a story about visas either. It is a story about a home system that cannot yet absorb the oncology, cardiac and orthopaedic demand its own population generates. Medical tourism on this scale is, as ever, a symptom of the gap between what patients need and what the domestic system supplies.
That framing sets the risk as well as the opportunity. A corridor this concentrated is an asset for Thailand and an exposure for both sides. For Thailand, a single fast-growing source market rewards the referral offices and Bangla-speaking desks MedPark has already built. For Bangladesh, 65,000 outbound patients a year is capital and clinical demand leaving the country, and the durable answer is home capacity rather than a faster visa queue. The embassy’s own framing, that it facilitates access rather than promotes it, is the honest one, because the demand is being met abroad only because it is not yet being met at home.
What to watch next in Thailand
The tests are specific and countable. Whether the 60 per cent medical share of embassy visas holds or rises will show if the corridor is still widening. Whether MedPark’s near 300 per cent growth in Bangladeshi patients is a one-year base effect or a durable trend will show in next year’s figure, not this year’s press conference. Whether the e-visa platform keeps two-week processing under peak-season load of 800 to 1,000 applications a day will decide how much of the logistics advantage Thailand actually keeps. The numbers Chirasawadi disclosed are a strong read on demand. The same numbers, a year on, will show whether Thailand has held the corridor or merely opened it.
